Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cumberland Pharmaceuticals

4.98
-1.3900-21.82%
Volume:137.03K
Turnover:781.36K
Market Cap:69.93M
PE:-10.81
High:6.39
Open:6.39
Low:4.98
Close:6.37
Loading ...

BRIEF-Cumberland Pharmaceuticals Announces Phase 2 Fight Dmd Trial Results For Duchenne Muscular Dystrophy Heart Disease

Reuters
·
04 Feb

Cumberland reports ‘positive’ results from Phase 2 FIGHT DMD trial

TIPRANKS
·
04 Feb

Cumberland Pharmaceuticals Announces Breakthrough Results From the Phase 2 Fight Dmd Trial in Duchenne Muscular Dystrophy Heart Disease

THOMSON REUTERS
·
04 Feb

Cumberland Pharmaceuticals Inc - Ifetroban Well-Tolerated With No Serious Drug-Related Events

THOMSON REUTERS
·
04 Feb

Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease

PR Newswire
·
04 Feb

3 US Penny Stocks With Market Caps Over $30M

Simply Wall St.
·
17 Jan

3 Promising Penny Stocks With Market Caps Under $2B In US

Simply Wall St.
·
11 Dec 2024

Cumberland Stock Soars 90% After FDA Approval for Acetadote Dosing Change

GuruFocus.com
·
11 Dec 2024

Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?

Benzinga
·
11 Dec 2024

Dow Falls 150 Points; Oracle Posts Downbeat Results

Benzinga
·
10 Dec 2024

Cumberland Pharmaceuticals Shares More Than Double After FDA Approves Co's Paracetamol Overdose Drug

THOMSON REUTERS
·
10 Dec 2024

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday

MT Newswires Live
·
10 Dec 2024

Investors Look Ahead to Key Inflation Data as US Futures Tread Water in Tuesday's Premarket

MT Newswires Live
·
10 Dec 2024

Top Premarket Gainers

MT Newswires Live
·
10 Dec 2024

Cumberland Pharmaceuticals Shares More Than Double Premarket After FDA Approves Co's Paracetamol Overdose Drug

THOMSON REUTERS
·
10 Dec 2024

BUZZ-Cumberland Pharma soars on FDA approval for paracetamol overdose drug

Reuters
·
10 Dec 2024